Navigation Links
The Efficacy Of Newer Stents Questioned

People who undergo a balloon angioplasty to open a clogged artery often receive a stent as well a small, wire-mesh device inserted into the artery// to keep it from closing. The problem with older stents, however, has been that they can trigger an immune response from the cells in the walls of the artery that cause the artery to become occluded.

Stents coated with drugs to stop this process have been touted as the answer to this problem. Researchers after having collected data from 11 studies comparing bare-metal stents with the newer drug-eluting stents say that their results show people who had the drug-eluting stents were significantly less likely than those receiving the bare-metal stents to experience severe cardiac events, 8 percent vs. 16 percent. They were also more likely to avoid an episode of restenosis, or reblocking of the artery, six to 12 months later, a common problem for anyone undergoing balloon angioplasty. Thirty percent of the bare-metal stent patients experienced reblockage compared to just 9 percent of those who got a drug-eluting stent.

The analysis found no difference in mortality rates or subsequent heart attacks in the two groups. However researchers say long term follow-up is needed to fully determine the safety and effectiveness of drug-eluting stents, especially in patients considered at high risk of complications.
'"/>




Page: 1

Related medicine news :

1. Efficacy Of Meningitis C Vaccine
2. The Efficacy Of Allergy Shots Questioned
3. The Efficacy Of Hormone Replacement Therapy Studied
4. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
5. Efficacy of fish oil supplements in pregnancy.
6. Efficacy of Omega 3 Fatty Acids Needs Wider Perspective
7. Thailand To Test Efficacy Of Stem Cell Technology
8. Efficacy Of Sports-Formulated Jelly Beans In Warding Off Fatigue To Be Studied
9. Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs
10. New Study Shows Efficacy of AROMASIN on Early Breast Cancer
11. KADIAN Efficacy Not Affected by Alcohol Consumption
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... According to the American Society of Plastic Surgeons ... among the top 5 most popular minimally-invasive cosmetic procedures in the country. With summer ... performed over the next 8-10 weeks. For anyone considering a hair removal procedure, there ...
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, a leader in training ... Readmissions Through Discharge Planning ” with noted expert Sue Dill Calloway, RN, MSN, ... strategies to prevent readmissions in light of the most recent programs at the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... and women’s professional squash, announced it has enlisted New York City-based sports and ... agency will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sublime Naturals ... "Spice of Life" or "Wonder Spice", it has been used for thousands of years. ... the East," says Heshelow, author of " Turmeric: How to Use it For Your ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: